A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...

The alarming rise in advanced prostate cancer cases in California, increasing way faster than the national average, has ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...

David James, director of patient projects and influencing at Prostate Cancer Research, has set the record straight on some of ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

The pharma giant hosted its ninth annual Blue Jacket Fashion Show in collaboration with designer Frederick Anderson in New ...

Radiotherapy, a standard of care treatment for localized prostate cancer includes, has shown remarkable success. This ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

"RedHill Biopharma launches trial of combination therapy for prostate cancer" was originally created and published by ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...